1.2 Original 2023 Hearings

The original in-person hearings for the National Citizens Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada were held from March through May 2023. These hearings took place in eight Canadian cities from coast to coast. In addition, a series of three virtual hearings were conducted in order to accommodate witnesses who wished to update their original testimony due to subsequent new information and to accommodate one additional witness who had not been able to testify during the 2023 hearings.

Following is a list of the cities and dates where the original National Citizens Inquiry hearings were held in 2023:

1. Truro, Nova Scotia

• March 16, 2023

• March 17, 2023

• March 18, 2023

1. Toronto, Ontario

• March 30, 2023

• March 31, 2023

• April 1, 2023

1. Winnipeg, Manitoba

• April 13, 2023

• April 14, 2023

• April 15, 2023

1. Saskatoon, Saskatchewan

• April 20, 2023

• April 21, 2023

• April 22, 2023

1. Red Deer, Alberta

• April 26, 2023

• April 27, 2023

• April 28, 2023

1. Langley, British Columbia

• May 2, 2023

• May 3, 2023

• May 4, 2023

1. Québec City, Québec

• May 11, 2023

• May 12, 2023

• May 13, 2023

1. Ottawa, Ontario

• May 17, 2023

• May 18, 2023

• May 19, 2023

1. Virtual Hearings

• June 28, 2023

• July 19, 2023

• September 18, 2023

Following the completion of the National Citizens Inquiry hearings into the appropriateness and effectiveness of the COVID-19 response in Canada, the Commissioners prepared a comprehensive report and submitted that report to the Commission on November 28, 2023.

Dire Nature of the 2023 Findings

The Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada, published on November 28, 2023, presented a comprehensive and urgent assessment of Canada’s handling of the COVID-19 pandemic.

The findings were stark and concerning, and they highlighted systemic failures, questionable policy decisions, and significant adverse effects on the health and well being of Canadians. The original NCI 2023 Report underscored the profound consequences of the measures taken during the pandemic, including economic disruption, mental health crises, and, most alarmingly, the health impacts of the COVID-19 vaccines.

Despite the meticulous efforts of the NCI to ensure that the 2023 Report reached every Canadian and the global audience, including those responsible for Canada’s COVID-19 response, the reaction has been disappointingly inadequate.

The Commission’s intent was to spark meaningful dialogue and prompt corrective actions. However, from the date of publication to the present, there has been a glaring absence of concrete action from the Canadian government and other relevant authorities. The recommendations and warnings issued in the 2023 Report have largely gone unheeded.

Lack of Governmental Response

The lack of action from the Canadian government is particularly concerning given the serious nature of the findings. The 2023 Report laid bare the critical need for transparency, accountability, and immediate policy reform to address the adverse effects identified. Yet the inertia observed in governmental response suggests a troubling disregard for the well being of the Canadian populace. This inaction not only continues to place Canadians at risk but also undermines the efforts of the NCI.

Emergence of New Critical Information

Since the release of the 2023 Report, significant additional information has surfaced, further compounding the concerns initially raised. New data and studies have revealed more about the side effects and profound health risks associated with the COVID-19 vaccines. These emerging insights have brought to light the long-term implications of the vaccines, which were not fully understood or acknowledged at the time of the first report. The alarming rise in adverse health outcomes, including serious side effects and potential long-term health risks, underscores the need for immediate and decisive action.

Compelled to Act: The Regina Hearings

In light of the government’s lack of response and the gravity of the new information, the NCI felt an ethical and moral obligation to continue its inquiry. Consequently, the NCI conducted additional supplemental hearings in Regina, Saskatchewan on May 30, 31, and June 1, 2024. These hearings aimed to shed light on the new findings and to give voice to those affected by the ongoing repercussions of the COVID-19 response. Over the course of these three days, the Commission gathered fresh testimonies and evidence to further elucidate the issues at hand.

The Regina hearings were driven by a commitment to truth, transparency, and the protection of public health. The NCI sought to highlight the critical need for informed policy changes and to urge the Canadian government to finally take the necessary actions to address the dire situations revealed.Structure and Operation of the National Citizens Inquiry

The description of the structure and operation of the National Citizens Inquiry as outlined in the original November 28, 2023 Report remains unchanged.

For a detailed understanding of these foundational aspects, readers are referred to Sections 1.3 through 1.11 of the 2023 Report.

These sections comprehensively cover the various elements that constitute the NCI’s framework and its operational procedures. Below are the section headings from the 2023 Report:

Sections from the original November 28, 2023 Report

1.3 Guiding Principles

1.4 Purposes of the National Citizens Inquiry

1.5 Structure of the National Citizens Inquiry

1.6 Selection of Commissioners

1.7 Instruction to the National Citizens Inquiry

1.8 Public Hearings

1.9 Identification and Classification of COVID-19 Interventions

1.10 Assessing the Effects of COVID-19 Interventions

1.11 Assessing the Appropriateness and Efficacy of These C-19 Interventions

For further information on these topics, please consult the original November 28, 2023 Report. These sections provide a thorough explanation of how the NCI was designed and operated to fulfill its mission of investigating and assessing the COVID-19 response in Canada.